PS

Pluristem Therapeutics

- NASDAQ:PSTI
Last Updated 2024-04-23
  • Therapeutic Products Derived from Non-Controversial Adult Stem Cell Source

  • Locations

    • Haifa Hefa

  • Total Funding (USD)

    15.0 million

  • Industries

    Mobile Apps

  • Security

    Type: ORD
    CUSIP: 72940R300
    ISIN: US72940R3003
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo